Krishna A Rao MD
Associate Professor, Internal Medicine, Southern Illinois University School of Medicine
Join to View Full Profile
415 N 9th StSpringfield, IL 62702
Phone+1 217-545-5817
Fax+1 217-545-7021
Dr. Rao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Krishna Rao is an oncologist based in Springfield, IL, specializing in acute myeloid and lymphoid leukemia. He completed his medical degree at the University of Miami Leonard M. Miller School of Medicine in 1991, followed by a residency in internal medicine at the Mayo Clinic and a fellowship in hematology and medical oncology at the University of Washington. His recent publications focus on cancer treatment methodologies, including the impact of cytotoxic chemotherapy and clinical trials such as those involving cetuximab, tivantinib, and veliparib for various cancers. He has contributed significantly to research, with publications cited multiple times in the medical community.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1994 - 1997
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1991 - 1994
University of Miami Leonard M. Miller School of MedicineClass of 1991
Certifications & Licensure
IL State Medical License 2002 - 2026
FL State Medical License Active through 2014
MN State Medical License 1992 - 1994
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma Start of enrollment: 2010 Apr 15
- Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity Start of enrollment: 2010 Dec 01
- Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery Start of enrollment: 2011 Jun 20
- Join now to see all
Publications & Presentations
PubMed
- Dendritic Cell-Derived Extracellular Vesicles as Therapeutic Cancer Vaccines: Mechanisms and Optimization Strategies.Jonathan Shpigelman, Krishna Rao
Immunology. 2025-09-02 - A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course o...Christina Henson, Daniel Clayburgh, Arielle Lee, Deborah Wong, Mahesh Kudrimoti
Cancers. 2025-05-14 - 1 citationsCharacteristics, Treatment, and Survival of Male Breast Cancer: A 21-year Retrospective Analysis at a Community Academic Institute in Central Illinois.Waqas Azhar, Ricardo Cossyleon, Syeda Fatima Kamal, Kristin Delfino, Kathy Robinson
Cancer Control. 2025-04-20
Press Mentions
Male Breast Cancer: Diagnosis, Treatment, and SurvivalJune 18th, 2025
Illinois University to Begin New Cancer Specialist TrainingFebruary 18th, 2019
Illinois University to Begin New Cancer Specialist TrainingFebruary 17th, 2019
Professional Memberships
- Member
Other Languages
- Kannada
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
